Supplementary Data from Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells

Authors:
  • YYYoung-Kwang Yoon
    Young-Kwang Yoon
  • HKHwang-Phill Kim
    Hwang-Phill Kim
  • SHSae-Won Han
    Sae-Won Han
  • HHHyung-Seok Hur
    Hyung-Seok Hur
  • DODo Youn Oh
    Do Youn Oh
  • SISeock-Ah Im
    Seock-Ah Im
  • YBYung-Jue Bang
    Yung-Jue Bang
  • TKTae-You Kim
    Tae-You Kim

Abstract
Supplementary Data from Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells